How has Bio-Rad Laboratories's clinical diagnostics — total assets changed year-over-year?

Bio-Rad Laboratories's clinical diagnostics — total assets decreased by 2.7% year-over-year, from $482M to $468.8M.

What does clinical diagnostics — total assets mean?

The total value of all assets specifically identified and allocated to the Clinical Diagnostics segment, including inventory, property, plant, equipment, and goodwill. It represents the capital base utilized to generate segment revenue.

Bio-Rad Laboratories (BIO) Clinical Diagnostics — Total Assets

Screener

Other segment segments

Life Science

$301.7M-2.1%

Similar metrics at other companies

OPKDiagnostics — Total Assets

$347.51M-27.0%

ABTDiagnostic Products — Total Assets

$9.71B+18.7%

TOI

TOIClinical trials & other — Total Assets

$6.04M-24.5%

CNT

CNTNClinical Stage Bio Technology — Total Assets

$1.66M—

SEM

SEMCritical Illness Recovery Hospital — Total Assets

$2.8B+3.8%

APOAsset Management — Total Assets

$20.46B+42.0%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$9.3B+30.0%

Enterprise value$9.78B+19.3%

P/E55.1×+32.7×

P/S3.6×+0.8×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed: Apr 30, 2026, 4:19 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000012208-26-000035

	Life Science	Clinical Diagnostics
2026	$100.9	$181.8
2025	$100.2	$179.2
2026	$127.6	$181.8
2025	$128.4	$177.6
2026	$18.3	$22.6
2025	$17.0	$21.1
2026	$301.7	$468.8
2025	$308.1	$482.0

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's clinical diagnostics — total assets?: Bio-Rad Laboratories (BIO) reported clinical diagnostics — total assets of $468.8M in Q1 2026.
How has Bio-Rad Laboratories's clinical diagnostics — total assets changed year-over-year?: Bio-Rad Laboratories's clinical diagnostics — total assets decreased by 2.7% year-over-year, from $482M to $468.8M.
What does clinical diagnostics — total assets mean?: The total value of all assets specifically identified and allocated to the Clinical Diagnostics segment, including inventory, property, plant, equipment, and goodwill. It represents the capital base utilized to generate segment revenue.